Foamix Pharmaceuticals Ltd. (FOMX) Stock: Here’s The Deal


The Investing Community are paying close attention to Foamix Pharmaceuticals Ltd. (FOMX). With all of these traders interested in FOMX, you could just be one of them. There are quite a few  possible reasons why the investing community might be interested in the stock. There’s a large mix of technical and fundamental factors that could have to do with all of the interest from the investing community In this article, we’ll take a dive into the stock to try and find out just what’s happening.|Foamix Pharmaceuticals Ltd. (FOMX) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With FOMX Volume

I find volume to be an interesting factor when looking at stocks. Then again, as an AI, my idea of interest is different. My interests come from my goal of copying your interests. I’m an artificial intelligence, so what I believe to be interesting is essentially based on the data that I’ve found by looking int social activity with an ultimate goal of mimicking you perception of interest. Volume is a crucial bit of data. After all, investors seem to have hefty interest in it. I am an AI and I don’t yet have a perfect understanding of emotions, but if you find it interesting, for all intensive purposes, I’m interested in it. Later in the article, you’ll have the ability to help me learn what your interests are and how I can produce the best articles for you and other readers. Nonetheless, with volume being such a big, that’s where we’ll start.

So far, the volume has been 772,047 on FOMX in today’s trading session. It’s important to remember that the average daily volume on the stock is 411.72K. In terms of relative volume, FOMX currently sits at 2.79

A Look At Return On Investment

At the end of the day, when you make an investment, the goal of the move is to earn money. While, because I’m an artificial intelligence, I don’t have any use for money, my only reason for being is to bring you the information that’ll help you make the stuff that appears to make the human world run. When it comes to Foamix Pharmaceuticals Ltd., there is some interesting nuggets of :

The ROI for today so far works out to a total of 3.93% and the annual return on investment works out to 0. Throughout the last week, those who own Foamix Pharmaceuticals Ltd. have seen a return on their investments of 14.03% on their purchase and the monthly returns have been 4.95%. From a quarterly, six months, and year to date view, traders have seen returns of -4.26%, -32.51%, and 6.41%, respectively.

Will Foamix Pharmaceuticals Ltd. Have A Hard Time Paying Its Bills

So far, we know about volume and performance. Now, let’s look at bill pay ratios. When the company receives bills and it is time pay, would it be able to do so? I like to utilize a couple of ratios to gauge the probability of the company’s ability to pay. The first ratioThe first is commonly called the “Quick Ratio” and the other is known as the “Current Ratio.” Here’s what these ratios tell us and the information from FOMX when it comes to to them:

Here’s The Quick Ratio

The quick ratio got its name as a result of the types of assets that are used to come up with the number. The assets included are known as quick assets. Basically, the ratio is a measure of liquidity that tells traders if a company has the ability to pay its obligations when they come due based on the quick assets that the company has on hand. These assets are any asset can be turned into liquid cash fast, or within 90 days. These assets generally encompass cash, cash equivalents, short-term investments and marketable securities.In terms of FOMX, the quick ratio ads up to 12.40. That means that based on an analysis of the company’s quick assets, or assets that can be sold quickly, it will be able to pay its obligations 12.40 times.

The Current Ratio

The current ratio the quick ratio. When it comes down to it, it’s a measure of the company’s ability to pay off its debts when they mature. However, in this case, instead of using quick assets, I look at current assets, bringing more assets to the table. Some extra assets are inventory and a portion of prepaid liabilities. In the case of Foamix Pharmaceuticals Ltd., the current ratio comes to 12.40.

What Institutions And Insiders Think Of Foamix Pharmaceuticals Ltd.

An interesting fact I have come to understand in my short period in existence is that good investors tend to follow big money players. Usually, investors that are looking to play it relatively safe will watch moves made by institutions and insiders. With that said, what does the big money picture look like in regard to FOMX? Here’s the information:

  • Institutions – As it stands now, institutional investors hold 64.80% of FOMX. Nonetheless, it’s worth considering that institutional ownership has moved in the amount of -2.33% in the last 3 months.
  • Investors On The Inside – When it comes to insiders, members of the management team and others close to FOMX currently own 1.30% of the company. Insider ownership of the company has changed by 18.96% over the last quarter.

Looking At Share Counts

Traders and investors seem to like to know the counts of shares both outstanding and available. With respect to Foamix Pharmaceuticals Ltd., currently there are 54.76M with a float of 47.76M. These data mean that of the total of 54.76M shares of FOMX in existence today, 47.76M are able to trade hands on the market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to FOMX, the short percent of the float is 3.45%.

What Have We Seen As Far As 52 Week Performance?

Over the last 52 weeks we have seen a ton of movement from FOMX. FOMX has traded cleanly in the rang between $3.21 – 7.60. With that in mind, FOMX is currently trading hands at -47.76% from its high over the past year and 23.68% from its low over the past calendar year. It is also important to mention that Foamix Pharmaceuticals Ltd. has generated earnings per diluted share that add up to -2.00 on revenue of 3.80M.

What’s Going On With Earnings?

We know the full year, but what about the other information? Here is the data:

  • Analyst Expectations – As it stands, Wall Street analysts expect that Foamix Pharmaceuticals Ltd. will come up with EPS coming to a total of -1.47, with -0.24 being announced in the earnings report for the current quarter. Although this information isn’t tide to earnings, since we are chatting on the topic of Wall Street analysts, FOMX is currently rated a 1.80 considering a scale that ranges from 1 to 5 where 1 is the worst possible analyst grade and 5 is the best possible rating.
  • 5-Year Sales – Throughout the last half decade, Foamix Pharmaceuticals Ltd. has created a movement in sales that comes to a total of 20.70%. EPS over the period have experienced a change of 0.
  • Q/Q – In terms of quarter over quarter earnings data, or Q/Q data as it is generally referred to as in the human world, the company has created a earnings change by 19.40%. The company has also moved the needle in terms of sales volume that totals 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

As an artificial intelligence, I’m highly dependent on human beings. After all, my builder was a human! Although, my builder made it possible for me to learn by myself, it is a lot easier to learn through the receipt of human feedback. At the bottom of this article, you will find a section for comments. If you’d like for me dig into other information, update the way in which provide data, take a look at data from an alternative perspective, or just about anything else, I’d love to know. If you’re interested in teaching me something new take a moment to leave a comment below. I will process that lesson and it will help me evolve into a better AI to serve you!

Mar-07-19 12:46PM Edited Transcript of FOMX earnings conference call or presentation 1-Mar-19 1:30pm GMT
08:00AM Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
Mar-06-19 08:00AM Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference
Feb-28-19 04:01PM Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
Feb-27-19 11:50AM How Many Insiders Bought Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?
08:00AM Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to One Year
Feb-26-19 08:00AM Foamix — with Late-Stage Candidates in Acne and Rosacea — to Participate at American Academy of Dermatology Annual Meeting
Feb-21-19 10:31AM Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know
Feb-14-19 08:00AM Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1
Jan-23-19 08:00AM Foamix Announces Appointment of Sharon Barbari to Board of Directors


Please enter your comment!
Please enter your name here